Announcements Trials
Browse Landscape

Phase

Phase 2 66Phase 1 18Phase 1/2 15Phase 3 12Phase NA 3Phase 2/3 3Phase 4 2

Status

Unknown 6Completed 6Terminated 3Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Gastrointestinal 1Breast 1

Conditions

Pancreatic Neoplasms 1Neoplasm Metastasis 1Breast Neoplasms 1

Interventions

Radiosurgery 28Magnetic Resonance Spectroscopy 25Blood Specimen Collection 20Radiotherapy 19Surveys and Questionnaires 18Exercise 17Early Intervention, Educational 17Methods 16Standard of Care 15Cyclophosphamide 15Surgical Procedures, Operative 14Radiotherapy, Intensity-Modulated 14Biopsy 13Acupuncture Therapy 12Interviews as Topic 11Educational Status 11Cisplatin 11Filgrastim 10Radiofrequency Ablation 9Magnetic Resonance Imaging 9Fluorodeoxyglucose F18 9fludarabine phosphate 8Radiation 8Practice Guidelines as Topic 8Gemcitabine 8X-Rays 7Sorafenib 7Granulocyte Colony-Stimulating Factor 7Colonoscopy 7Capecitabine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Terminated × Erlotinib Hydrochloride × Clear all
NCT01683422 2021-08-10

Chemotherapy Plus Proton-chemotherapy for Locally Advanced Pancreatic Cancer

Loma Linda University

Phase NA Terminated
9 enrolled 8 charts
Gastrointestinal

Pancreatic Neoplasms

NCT01190241 2020-11-20

TSAP

Amsterdam UMC, location VUmc

Phase NA Terminated
45 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT00503841 2019-04-30

Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer

Barbara Ann Karmanos Cancer Institute

Phase NA Terminated
44 enrolled 3 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡